Product Information

QBRELIS 1 MG/ML SOLUTION is a brand product labeled by Azurity Pharmaceuticals Inc., priced at $4.4804 per ML under NDC 52652300101. Its NADAC has been published 197 times since Sep 21, 2022.

The High Outlier badge above means this manufacturer's average price in the lisinopril market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.

QBRELIS 1 MG/ML SOLUTION

lisinopril
$4.4804per ML
High Outlier

Strength

1 mg/mL

NDC

52652300101

Classification

Brand

Dosage Form

SOLUTION

Route

ORAL

Last Updated

6/17/2026

Active Ingredients

LISINOPRIL

Approval Type

New Drug (NDA)

FDA Application

NDA208401

On Market Since

8/29/2016

Pharmacological Classes

Angiotensin Converting Enzyme Inhibitor
Angiotensin-converting Enzyme Inhibitors

Price Statistics

The NADAC for QBRELIS 1 MG/ML SOLUTION has been published 197 times since Sep 21, 2022, and over the history we have for it it has risen 30.9%. The table below summarizes its recorded NADAC range and movement.

Current price$4.4804 per ML
All-time high$4.4804 (Jun 24, 2026)
All-time low$3.4237 (Sep 21, 2022)
52-week high$4.4804
52-week low$4.3447
Median price$4.0021
Average price$4.0509
Largest weekly change+9.8% (Jan 4, 2023)
Weeks tracked197
Tracking sinceSep 21, 2022

Price History

1W

0.0%

1M

+0.3%

3M

+0.1%

6M

+3.1%

1Y

+3.0%

3Y

+19.2%

5Y

N/A

All

+30.9%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient, strength, and dosage form. Compare the broader picture on the lisinopril market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient, strength, and dosage form.

Frequently asked questions

What is the NADAC price of QBRELIS 1 MG/ML SOLUTION?

The current National Average Drug Acquisition Cost (NADAC) for QBRELIS 1 MG/ML SOLUTION, manufactured by Azurity Pharmaceuticals Inc., is $4.4804 per ML (NDC 52652300101), effective Jun 24, 2026.

How has the price of QBRELIS 1 MG/ML SOLUTION changed over time?

Over the history we have for it, the NADAC for QBRELIS 1 MG/ML SOLUTION has risen 30.9%. It has been tracked across 197 weekly CMS publications since Sep 21, 2022.

What are the highest and lowest recorded NADAC prices for QBRELIS 1 MG/ML SOLUTION?

Since Sep 21, 2022, the NADAC for QBRELIS 1 MG/ML SOLUTION has ranged from a low of $3.4237 (Sep 21, 2022) to a high of $4.4804 (Jun 24, 2026), with a median of $4.0021 per ML.

Are there cheaper alternatives to QBRELIS 1 MG/ML SOLUTION?

No other NADAC-published product currently shares the active ingredient, strength, and dosage form of QBRELIS 1 MG/ML SOLUTION, so no direct lower-cost alternative is listed.

Who manufactures QBRELIS 1 MG/ML SOLUTION?

QBRELIS 1 MG/ML SOLUTION (NDC 52652300101) is labeled by Azurity Pharmaceuticals Inc., and CMS classifies it as a brand product.